Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B (Hepatoma Research)

Peter D. Block; Brianna J. Shinn; Christopher G. Roth; Jeffrey P. Baliff; Ralph G. Zinner; Hie Won Hann

doi:10.20517/2394-5079.2019.017

Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B (Hepatoma Research)

Peter D. Block
, Brianna J. Shinn
, Christopher G. Roth
, Jeffrey P. Baliff
, Ralph G. Zinner
, Hie Won Hann

Producción científica: Comment/debate

Resumen

The Case Report was published on 21 Jun 2019. The author's statement of conflict of interest was confused with the original and published incorrectly due to the negligence of the Editorial Office. Here is the correction: Conflict of Interest: Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences. Ralph Zinner: Bristol Myers Squibb, Merck Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest. We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.

Idioma original	English
Número de artículo	22
Publicación	Hepatoma Research
Volumen	5
DOI	https://doi.org/10.20517/2394-5079.2019.017
Estado	Published - 2019

Nota bibliográfica

Publisher Copyright:
© The Author(s) 2019.

Financiación

Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences. Ralph Zinner: Bristol Myers Squibb, Merck Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest.

Financiadores
Gilead Sciences

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being

ASJC Scopus subject areas

Hepatology
Oncology

Acceder al documento

10.20517/2394-5079.2019.017

Otros archivos y enlaces

Citar esto

@article{ee48b342c0304c64b911a47e387b0fb3,

title = "Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B (Hepatoma Research)",

abstract = "The Case Report was published on 21 Jun 2019. The author's statement of conflict of interest was confused with the original and published incorrectly due to the negligence of the Editorial Office. Here is the correction: Conflict of Interest: Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences. Ralph Zinner: Bristol Myers Squibb, Merck Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest. We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.",

author = "Block, \{Peter D.\} and Shinn, \{Brianna J.\} and Roth, \{Christopher G.\} and Baliff, \{Jeffrey P.\} and Zinner, \{Ralph G.\} and Hann, \{Hie Won\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2019",

doi = "10.20517/2394-5079.2019.017",

language = "English",

volume = "5",

journal = "Hepatoma Research",

issn = "2394-5079",

publisher = "OAE Publishing Inc.",

}

TY - JOUR

T1 - Correction

T2 - Three primary malignancies in 17 years in a man with chronic hepatitis B (Hepatoma Research)

AU - Block, Peter D.

AU - Shinn, Brianna J.

AU - Roth, Christopher G.

AU - Baliff, Jeffrey P.

AU - Zinner, Ralph G.

AU - Hann, Hie Won

PY - 2019

Y1 - 2019

N2 - The Case Report was published on 21 Jun 2019. The author's statement of conflict of interest was confused with the original and published incorrectly due to the negligence of the Editorial Office. Here is the correction: Conflict of Interest: Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences. Ralph Zinner: Bristol Myers Squibb, Merck Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest. We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.

AB - The Case Report was published on 21 Jun 2019. The author's statement of conflict of interest was confused with the original and published incorrectly due to the negligence of the Editorial Office. Here is the correction: Conflict of Interest: Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences. Ralph Zinner: Bristol Myers Squibb, Merck Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest. We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.

UR - https://www.scopus.com/pages/publications/85150877921

UR - https://www.scopus.com/pages/publications/85150877921#tab=citedBy

U2 - 10.20517/2394-5079.2019.017

DO - 10.20517/2394-5079.2019.017

M3 - Comment/debate

AN - SCOPUS:85150877921

SN - 2394-5079

VL - 5

JO - Hepatoma Research

JF - Hepatoma Research

M1 - 22

ER -

Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B (Hepatoma Research)

Resumen

Nota bibliográfica

Financiación

ODS de las Naciones Unidas

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto